Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kymera Therapeutics (KYMR) Other Working Capital Changes: 2019-2025

Historic Other Working Capital Changes for Kymera Therapeutics (KYMR) over the last 6 years, with Sep 2025 value amounting to -$2.8 million.

  • Kymera Therapeutics' Other Working Capital Changes fell 14.03% to -$2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.2 million, marking a year-over-year increase of 400.06%. This contributed to the annual value of -$41.1 million for FY2024, which is 321.05% down from last year.
  • Latest data reveals that Kymera Therapeutics reported Other Working Capital Changes of -$2.8 million as of Q3 2025, which was down 109.47% from $29.2 million recorded in Q2 2025.
  • Kymera Therapeutics' 5-year Other Working Capital Changes high stood at $38.1 million for Q4 2023, and its period low was -$23.9 million during Q2 2024.
  • Moreover, its 3-year median value for Other Working Capital Changes was -$2.8 million (2025), whereas its average is $106,091.
  • In the last 5 years, Kymera Therapeutics' Other Working Capital Changes slumped by 436.28% in 2021 and then spiked by 379.88% in 2023.
  • Over the past 5 years, Kymera Therapeutics' Other Working Capital Changes (Quarterly) stood at -$15.1 million in 2021, then climbed by 10.15% to -$13.6 million in 2022, then soared by 379.88% to $38.1 million in 2023, then slumped by 116.94% to -$6.4 million in 2024, then fell by 14.03% to -$2.8 million in 2025.
  • Its Other Working Capital Changes was -$2.8 million in Q3 2025, compared to $29.2 million in Q2 2025 and -$2.8 million in Q1 2025.